You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 7, July 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (85)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cutaneous Histiocytosis X

The Presence of S-100 Protein and Its Use in Diagnosis

Geoffrey Rowden, PhD, MRC(Pathol); Eileen M. Connelly; Richard K. Winkelmann, MD, PhD

Arch Dermatol. 1983;119(7):553-559.


Abstract

• The cellular localization of glial S-100 protein was investigated in paraffin-embedded sections of cutaneous histiocytosis X and in a variety of cutaneous infiltrative disorders, including juvenile xanthogranuloma, necrobiotic xanthogranuloma, papular xanthoma, eruptive histiocytoma, and reticulohistiocytosis. Immunoperoxidase staining with a rabbit anti-calf brain-S-100 antibody demonstrated strong and consistent activity in atypical histiocytes in all histiocytosis X specimens. No detectable S-100 protein was demonstrated in either histiocytes or giant cells in the non-X histiocytic disorders investigated. Positive controls were included within both groups of disorders in respect to melanocyte, epidermal Langerhans' cell, and dermal Schwann's cell staining. These findings are interpreted as evidence for diversity in the mononuclear phagocyte system and demonstrate the practicality of such a simple test in diagnostic problems involving infiltrative histiocytic disorders of the skin.

(Arch Dermatol 1983;119:553-559)



Author Affiliations

From the Pathology Department, Stritch School of Medicine, Loyola University, Maywood, Ill (Dr Rowden and Ms Connelly); and the Dermatology Department, Mayo Clinic, Rochester, Minn (Dr Winkelmann).


Footnotes

Accepted for publication Nov 23, 1982.

Reprint requests to the Pathology Department, Stritch School of Medicine, Loyola University, 2160 S First Ave, Maywood, IL 60153 (Dr Rowden).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Histologic and Immunohistochemical Study Comparing Xanthoma Disseminatum and Histiocytosis X
Zelger et al.
Arch Dermatol 1992;128:1207-1212.
ABSTRACT  

Primary Cutaneous Langerhans Cell Histiocytosis in an Adult
Lichtenwald et al.
Arch Dermatol 1991;127:1545-1548.
ABSTRACT  

Benign Cephalic Histiocytosis
Gianotti et al.
Arch Dermatol 1986;122:1038-1043.
ABSTRACT  

Histiocytosis X: Flow Cytometric DNA-Content and Immunohistochemical and Ultrastructural Analysis
Goldberg et al.
Arch Dermatol 1986;122:446-450.
ABSTRACT  

Atypical Fibroxanthoma: A Study With Antibody to S-100 Protein
Winkelmann and Peters
Arch Dermatol 1985;121:753-755.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.